HN2009001021A - CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN- 1-IL) -PENYL] - PROPIONITRILE - Google Patents

CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN- 1-IL) -PENYL] - PROPIONITRILE

Info

Publication number
HN2009001021A
HN2009001021A HN2009001021A HN2009001021A HN2009001021A HN 2009001021 A HN2009001021 A HN 2009001021A HN 2009001021 A HN2009001021 A HN 2009001021A HN 2009001021 A HN2009001021 A HN 2009001021A HN 2009001021 A HN2009001021 A HN 2009001021A
Authority
HN
Honduras
Prior art keywords
quinolin
methyl
penyl
propionitrile
imidazo
Prior art date
Application number
HN2009001021A
Other languages
Spanish (es)
Inventor
Stowasser Frank
Banziger Markus
Devidrasrao Garad Sudhakar
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HN2009001021A publication Critical patent/HN2009001021A/en

Links

Abstract

LA INVENCION SE REFIERE A FORMAS CRISTALINAS PARTICULARES DE LA FORMULA SUS HIDRATOS Y SOLVATOS, SUS SALES E HIDRATOS Y SOLVATOS DE SUS SALES, A CIERTOS PROCESOS PARA SU PREPARACION, A COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTAS FORMAS CRISTALINAS Y A US USO EN METODOS DE DIAGNOSTICO O DE PREFERENCIA, PARA EL TRATMIENTO TERAPEUTICO DE ANIMALES DE SANGRE CALIENTE, EN ESPECIAL SERES HUMANOS Y A SU USO COMO UN INTERMEDIARIO O PARA LA PREPARACION DE LAS PREPARACIONES FARMACEUTICAS PARA UTILIZARSE EN METODOS DE DIAGNOSTICO O DE PREFERENCIA, PARA EL TRATAMIENTO TERAPEUTICO DE ANIMALES DE SANGRE CALIENTE , EN ESPECIAL LOS HUMANOSTHE INVENTION REFERS TO PARTICULAR CRYSTAL FORMS OF THE FORMULA ITS HYDRATS AND SOLVATES, ITS SALTS AND HYDRATS AND SOLVATOS OF ITS SALTS, TO CERTAIN PROCESSES FOR THEIR PREPARATION, TO PHARMACEUTICAL COMPOSITIONS CONTAINING THESE CRYSTALLINE USE METHODS AND TO PREFERENCE, FOR THE THERAPEUTIC TREATMENT OF HOT BLOOD ANIMALS, IN SPECIAL HUMAN BEINGS AND FOR USE AS AN INTERMEDIARY OR FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS TO BE USED IN METHODS OF DIAGNOSIS OR PREFERENCE, FOR TREATMENT OF SANITATION TREATMENT, IN SPECIAL HUMANS

HN2009001021A 2007-11-20 2009-05-19 CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN- 1-IL) -PENYL] - PROPIONITRILE HN2009001021A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86648307P 2007-11-20 2007-11-20

Publications (1)

Publication Number Publication Date
HN2009001021A true HN2009001021A (en) 2011-11-23

Family

ID=46801774

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2009001021A HN2009001021A (en) 2007-11-20 2009-05-19 CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN- 1-IL) -PENYL] - PROPIONITRILE

Country Status (1)

Country Link
HN (1) HN2009001021A (en)

Similar Documents

Publication Publication Date Title
CO6382134A2 (en) CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (METHYL-2-OXO-8-QUINOLIN-3-3IL-2,3-DIHIDRO-IMIDAZO- [4,5-C] -QUINOLIN-1- IL) -PENYL] PROPIONITRILE
CO2020007218A2 (en) New benzylamino-substituted pyridopyrimidinones and derivatives as sos1 inhibitors
GT201300080A (en) ELABORATION PROCESS FOR PIRIMIDINE DERIVATIVES
ECSP088217A (en) FORMS OF CRYSTAL DELTA AND EYESILON MESILATE IMATINIB
CO6400220A2 (en) SULFONAMIDE DERIVATIVES
SV2011003939A (en) VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES
GT200500307A (en) CHEMICAL COMPOUNDS
GT200600045A (en) DERIVATIVES OF PIRIDIZINE AND ITS USE AS THERAPEUTIC AGENTS
CU20110221A7 (en) DERIVATIVES OF 1H-IMIDAZO- [4,5-C] -QUINOLINONA
DOP2006000243A (en) PIRAZINE DERIVATIVES
NI201800051A (en) IMIDAZO [4, 5-C] QUINOLIN-2-ONA COMPOUNDS AND ITS USE IN THE TREATMENT OF CANCER
GT200600089A (en) ORGANIC COMPOUNDS
ECSP088869A (en) DERIVATIVES OF 2-PIRAZINONE FOR THE TREATMENT OF DISEASES OR CONDITIONS WHERE THE INHIBITION OF THE ACTIVITY OF NEUTROPHYLICAL ELASTASA IS BENEFICIAL
UY29964A1 (en) CRYSTAL FORMS F, G, H, I, AND K OF THE IMATINIB MESILATE
GT200500378A (en) MACROLIDOS
DOP2005000051A (en) OXADIAZOLONES, PROCEDURES FOR PREPARATION AND USE AS PHARMACEUTICAL PRODUCTS
PA8803201A1 (en) ACID DERIVATIVES OF CICLOALQUILAMINO
AR106364A1 (en) INSULIN DERIVATIVES AND THEIR MEDICAL USES
UY38625A (en) COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
DOP2017000018A (en) [1,2,4] TRIAZOLO [4,3-B] PIRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES
UY28356A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATIONS OF THE SAME AND ITS USES
UY28357A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION OF THE SAME AND ITS USES
UY31805A (en) AGONISTS M1, PHARMACEUTICAL COMPOSITIONS OF THE SAME, PROCESSES FOR THEIR PREPARATION AND ITS USES FOR THE TREATMENT OF PAIN
HN2009001021A (en) CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -QUINOLIN- 1-IL) -PENYL] - PROPIONITRILE
CU20090081A7 (en) CRYSTAL SALTS AND FORMS OF 2-METHYL-2- [4- (3-METHYL-2-OXO-8-QUINOLIN-3-IL-2,3-DIHYDRO-IMIDAZO- [4,5-C] -CHEMINOLIN- 1IL) -PENYL] -PROPIONITRILE